Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
This attribute specifies the denominator unit for the concentration strength of a product. |
mL |
true |
Inferred relationship |
Some |
2 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Some |
2 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
This attribute specifies the denominator unit for the concentration strength of a product. |
mL |
true |
Inferred relationship |
Some |
1 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Has manufactured dose form |
Conventional release eye solution (dose form) |
true |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Is a |
Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form) |
true |
Inferred relationship |
Some |
|
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Has concentration strength numerator value |
cinq |
false |
Inferred relationship |
Some |
1 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Neomycin sulfate |
true |
Inferred relationship |
Some |
1 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Hydrocortisone acetate |
true |
Inferred relationship |
Some |
2 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Has concentration strength numerator value |
15 |
false |
Inferred relationship |
Some |
2 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Hydrocortisone acetate |
true |
Inferred relationship |
Some |
2 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Neomycin (substance) |
true |
Inferred relationship |
Some |
1 |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|